Closing Bell: Knight Therapeutics Inc down on Tuesday (GUD)

Knight Therapeutics Inc opened trading today at $5.62 and closed at $5.57. prices ranged from a low of $5.50 to a high of $5.66.

Shares dipped -0.89% from the previous day's close of $5.62.

Today across North America, the TSX Composite closed 0.20% at 22824.67, the S&P 500 closed 0.08% at 5463.54, the Dow Jones Industrial Average closed -0.12% at 40539.93 and the Nasdaq Composite closed 0.07% at 17370.20.

Knight Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker GUD.

A total of 90,614 shares was traded during the session, with total trades of 395, while having an average volume of 52,648 in the last five days.

The TSX overall saw 2,584 price advancers against 2,644 declines and 86 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have boosted 15.80 percent in the last 12 months, while this year, they have advanced 7.32%.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $569.73 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..